Online citations, reference lists, and bibliographies.
← Back to Search

Uptake Of Liposomes By Cultured Mouse Bone Marrow Macrophages: Influence Of Liposome Composition And Size.

T. Allen, G. A. Austin, A. Chonn, L. Lin, K. Lee
Published 1991 · Chemistry, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
A wide range of liposome compositions have previously been examined in vivo for their ability to affect the uptake of liposomes into cells of the reticuloendothelial (RE, mononuclear phagocyte) system (Allen, T.M. and Chonn, A. (1987) FEBS Lett. 223, 42-46; Allen et al. (1989) Biochim. Biophys. Acta 981, 27-35). In this study we have examined the ability of cultured murine bone marrow macrophages to endocytose liposomes of various compositions and have looked for correlations between the in vivo and the in vitro observations. Compounds which substantially decreased RE uptake of liposomes in vivo, such as monosialoganglioside (GM1) and a novel synthetic lipid derivative of polyethyleneglycol (PEG-PE), also greatly decreased liposome uptake by bone marrow macrophages in a concentration-dependent manner. Lipids which increase bilayer rigidity, such as sphingomyelin (SM) and cholesterol (CHOL), decreased both in vivo and in vitro uptake of liposomes. Likewise, positive correlations were observed between the in vivo behavior of liposomes containing phosphatidylserine (PS) or various gangliosides and the ability of these liposomes to be taken up by bone marrow macrophages. Total liposome uptake by macrophages increased with incubation time at 37 degrees C while very little liposome association with the macrophages was observed at 4 degrees C. Liposome uptake increased with liposome concentration and for liposomes composed of egg phosphatidylcholine (PC) uptake plateaued at 40 nmol lipid per mg cell protein. There was an inverse correlation between liposome size of extruded large unilamellar vesicles and their uptake by macrophages.
This paper references
10.1016/0005-2736(89)90078-3
Liposomes with prolonged circulation times: factors affecting uptake by reticuloendothelial and other tissues.
T. Allen (1989)
10.1016/0005-2736(85)90244-5
Influence of liposome charge on the association of liposomes with Kupffer cells in vitro. Effects of divalent cations and competition with latex particles.
J. Dijkstra (1985)
10.1016/0005-2736(85)90519-X
Interactions of polymerized phospholipid vesicles with cells. Uptake, processing and toxicity in macrophages.
R. Juliano (1985)
10.1016/0304-4165(86)90020-6
Pinocytosis and phagocytosis: the effect of size of a particulate substrate on its mode of capture by rat peritoneal macrophages cultured in vitro.
M. Pratten (1986)
10.1016/0006-291X(84)90477-7
125I labelled inulin: a convenient marker for deposition of liposomal contents in vivo.
E. Sommerman (1984)
10.1016/0003-2697(76)90527-3
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.
M. M. Bradford (1976)
Functional heterogeneity of culture-grown bone marrow-derived macrophages. I. Antigen presenting function.
K. Lee (1980)
10.1111/J.1432-1033.1974.TB03681.X
Control of the rate of hepatic uptake and catabolism of liposome-entrapped proteins injected into rats. Possible therapeutic applications.
G. Gregoriadis (1974)
10.1016/0014-5793(80)80771-X
Biological stability of [3H]cholesteryl oleyl ether in cultured fibroblasts and intact rat
Y. Stein (1980)
10.1016/0378-5173(86)90199-7
The effect of hydrophilic coatings on the uptake of colloidal particles by the liver and by peritoneal macrophages
L. Ilium (1986)
10.1016/0005-2736(86)90302-0
Vesicles of variable sizes produced by a rapid extrusion procedure.
L. Mayer (1986)
10.1016/0167-4889(82)90120-3
Interactions of liposomes with the reticuloendothelial system. II: Nonspecific and receptor-mediated uptake of liposomes by mouse peritoneal macrophages.
M. J. Hsu (1982)
10.1016/0005-2736(79)90085-3
Preparation of liposomes of defined size distribution by extrusion through polycarbonate membranes.
F. Olson (1979)
10.1016/0022-1759(90)90331-O
Liposomes in the therapy of infectious diseases and cancer: Lopez-Berestein, G. and Fidler, I.J. (Eds.), 500 pp. Alan R. Liss, New York, 1989. USD 96.00, ISBN 0-8451-2688-1
F. Borek (1990)
10.1016/0167-4889(85)90112-0
Liposome uptake by cultured macrophages mediated by modified low-density lipoproteins.
V. O. Ivanov (1985)
10.1016/0014-5793(80)80994-X
The phospholipid component of small unilamellar liposomes controls the rate of clearance of entrapped solutes from the circulation
G. Gregoriadis (1980)
Effect of liposome size and drug release properties on pharmacokinetics of encapsulated drug in rats.
T. Allen (1983)
10.1016/s0021-9258(18)70226-3
Phosphorus assay in column chromatography.
G. R. Bartlett (1959)
10.1016/0304-4165(81)90341-X
In vivo fate of large unilamellar sphingomyelin-cholesterol liposomes after intraperitoneal and intravenous injection into rats.
H. Ellens (1981)
10.1016/0005-2736(75)90234-5
Tissue distribution of EDTA encapsulated within liposomes of varying surface properties.
M. Jonah (1975)
10.1016/0014-5793(82)81216-7
Is half‐life of circulating liposomes determined by changes in their permeability?
J. Senior (1982)
10.1016/0167-4889(88)90184-X
UPTAKE AND PROCESSING OF IMMUNOGLOBULIN-COATED LIPOSOMES BY SUBPOPULATIONS OF RAT-LIVER MACROPHAGES
J.T.P. Derksen (1988)
10.1016/0304-4165(83)90223-4
Inhibitory effect of cholesterol on the uptake of liposomes by liver and spleen.
H. M. Patel (1983)
10.1016/0014-4827(84)90711-0
Interaction of liposomes with Kupffer cells in vitro.
J. Dijkstra (1984)
10.1016/0005-2736(84)90521-2
The effects of charge and size on the interaction of unilamellar liposomes with macrophages.
R. Schwendener (1984)
10.1016/0005-2736(84)90118-4
Photopolymerized phospholipid vesicles Stability and retention of hydrophilic and hydrophobic marker substances
R. Juliano (1984)
10.1016/0003-2697(77)90043-4
A simplification of the protein assay method of Lowry et al. which is more generally applicable.
G. Peterson (1977)
Biological approaches to the controlled delivery of drugs: a critical review.
M. Poznansky (1984)
10.1016/0014-5793(87)80506-9
Large unilamellar liposomes with low uptake into the reticuloendothelial system
T. Allen (1987)
10.1016/0009-3084(86)90080-0
Liposome-cell interactions: in vitro discrimination of uptake mechanism and in vivo targeting strategies to mononuclear phagocytes.
A. Schroit (1986)
10.1111/J.1768-322X.1984.TB00303.X
The recognition of red blood cells by macrophages: role of phosphatidylserine and possible implications of membrane phospholipid asymmetry
A. Schroit (1984)
10.1111/j.2042-7158.1988.tb05212.x
Association of Liposome‐entrapped [3H]Methotrexate with Thioglycollate‐elicited Macrophages In‐vitro
W. Foong (1988)
10.1111/J.1432-1033.1985.TB08851.X
Uptake and processing of liposomal phospholipids by Kupffer cells in vitro.
J. Dijkstra (1985)



This paper is referenced by
10.3109/08982109509018630
Use of a Two Chamber Culture Apparatus to Examine Transendothelial movement of liposomes in vitro
Lei Lin (1995)
10.1016/J.IJPHARM.2006.08.026
Effect of coupling of albumin onto surface of PEG liposome on its in vivo disposition.
K. Furumoto (2007)
Uptake of nanoparticles by cells in experiments and models. The role of particle properties, test conditions and cell type
K. Kettler (2018)
10.1186/s11671-018-2728-6
Insight into Cellular Uptake and Intracellular Trafficking of Nanoparticles
Parisa Foroozandeh (2018)
10.1248/bpb.b16-00624
Liposomal Delivery Systems: Design Optimization and Current Applications.
Amr S Abu Lila (2017)
10.1007/s002490050199
Light scattering characterization of extruded lipid vesicles
A. Jin (1999)
10.1016/0304-4157(92)90004-T
Immunologic aspects of liposomes: presentation and processing of liposomal protein and phospholipid antigens.
C. Alving (1992)
10.1201/9781420006636.CH29
Applications of Liposomal Drug Delivery Systems to Cancer Therapy
A. Gabizon (2006)
10.7150/thno.4949
Cholesterol Derivatives Based Charged Liposomes for Doxorubicin Delivery: Preparation, In Vitro and In Vivo Characterization
Yu Nie (2012)
Liposomes thermosensibles furtifs pour l'administration du 5-Fluorouracile déclenchée par ultrasons
Chantal Al Sabbagh (2014)
10.1016/j.ctrv.2014.02.002
Bridging cancer biology and the patients' needs with nanotechnology-based approaches.
N. Fonseca (2014)
10.2147/IJN.S169935
A review on nanosystems as an effective approach against infections of Staphylococcus aureus
K. Zhou (2018)
10.1002/(SICI)1097-0126(199904)48:4<251::AID-PI104>3.0.CO;2-4
Polyoxyethylene-coated nanospheres: effect of coating on zeta potential and phagocytosis
R. Gref (1999)
10.1161/01.CIR.102.22.2745
Noninvasive Ultrasound Imaging of Inflammation Using Microbubbles Targeted to Activated Leukocytes
J. Lindner (2000)
10.1016/S0169-409X(99)00037-X
Mechanisms and kinetics of liposome-cell interactions.
Düzgüneş (1999)
Medical Design and Properties of a Lipid-Based Carrier
M. Monck (2001)
10.1182/BLOOD.V92.5.1785
Targeted Inactivation of Murine Band 3 (AE1) Gene Produces a Hypercoagulable State Causing Widespread Thrombosis In Vivo
H. Hassoun (1998)
10.1016/B978-044482917-7/50028-4
Toxicity of liposome-encapsulated hemoglobin: Effect of liposomal membrane composition on host defense, platelet activation and hemostases during laminar shear flow
J. Jato (1998)
10.1080/08982100802564628
In vitrouptake and antimycobacterial activity of liposomal usnic acid formulation
Mariane C. B. Lira (2009)
10.4155/tde-2018-0035
Long circulating liposomes: challenges and opportunities.
S. Deodhar (2018)
10.1002/9780470571224.PSE043
Accumulation of Drugs in Tissues
K. Venkatesan (2010)
10.1007/978-3-319-43525-1_4
Nanocarrier-Based Anticancer Therapies with the Focus on Strategies for Targeting the Tumor Microenvironment
F. Leonard (2016)
10.1021/mp200621v
In vivo biodistribution of prion- and GM1-targeted polymersomes following intravenous administration in mice.
Katica Stojanov (2012)
10.3748/wjg.v22.i26.5971
Pancreatic cancer stem cell markers and exosomes - the incentive push.
Sarah Heiler (2016)
PHARMACY-ON-A-CHIP: MICROFLUIDIC SYNTHESIS AND PREPARATION OF TUMOR-TARGETED LIPOSOMES
R. R. Hood (2014)
10.1016/J.JCONREL.2003.12.010
Site-specific microinjection of liposomes into the brain for local infusion of a short-lived peptide.
N. M. Silva-Barcellos (2004)
10.1016/S0928-0987(02)00241-5
The influence of lipid nanocapsule composition on their size distribution.
B. Heurtault (2003)
10.1016/S0005-2736(02)00468-6
Effect of liposome charge and PEG polymer layer thickness on cell-liposome electrostatic interactions.
N. Dan (2002)
10.1023/A:1016043431778
Interaction of Polyethyleneglycol-Phospholipid Conjugates with Cholesterol-Phosphatidylcholine Mixtures: Sterically Stabilized Liposome Formulations
R. K. Bedu-Addo (2004)
10.1016/0005-2736(95)00248-0
Poly(ethylene glycol)-coated anti-cardiac myosin immunoliposomes: factors influencing targeted accumulation in the infarcted myocardium.
V. Torchilin (1996)
10.1002/smll.201100442
More effective nanomedicines through particle design.
J. Wang (2011)
10.4081/ND.2011.E2
Albumin coated liposomes: a novel platform for macrophage specific drug delivery
Clément Vuarchey (2011)
See more
Semantic Scholar Logo Some data provided by SemanticScholar